JOHN C. REED - 01 May 2023 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, Pharmaceuticals R&D
Signature
Laura McFalls, as attorney-in-fact for John C. Reed
Issuer symbol
JNJ
Transactions as of
01 May 2023
Net transactions value
$0
Form type
4
Filing time
02 May 2023, 17:21:29 UTC
Previous filing
13 Apr 2023
Next filing
20 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Award $0 +75,765 $0.000000 75,765 01 May 2023 Common Stock 75,765 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.
F2 The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

Remarks:

grant of RSUs in connection with hire